Mapping the binding site on CD8β for MHC class I reveals mutants with enhanced binding

Journal of Immunology

Volumn 177, Issue 6, 2006, Pages 3930-3938

  Devine, Lesley ^a   Thakral, Deepshi ^a   Nag, Shanta ^a   Dobbins, Jessica ^a   Hodsdon, Michael E ^a   Kavathas, Paula B ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CD8ALPHA ANTIGEN; CD8BETA ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL STRAIN COS7; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FLUORESCENCE ACTIVATED CELL SORTING; HYBRIDOMA CELL CULTURE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 33748507804     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.6.3930     Document Type: Article

References (28)

1. Cawthon, A. G., H. Lu, and M. A. Alexander-Miller. 2001. Peptide requirement for CTL activation reflects the sensitivity to CD3 engagement: correlation with CD8αβ versus CD8αα expression. J. Immunol. 167: 2577-2584.
2. Maile, R., C. A. Siler, S. E. Kerry, K. E. Midkiff, E. J. Collins, and J. A. Frelinger. 2005. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo. J. Immunol. 174: 619-627.
3. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255-264.
4. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159: 565-573.
5. + lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J. Exp. Med. 173: 471-481.
6. Moebius, U., G. Kober, A. L. Griscelli, T. Hercend, and S. C. Meuer. 1991. Expression of different CD8 isoforms on distinct human lymphocyte populations. Eur. J. Immunol. 21: 1793-1800.
7. Garcia, K. C., C. A. Scott, A. Brunmark, F. R. Carbone, P. A. Peterson, I. A. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384: 577-581.
8. Leishman, A. J., O. V. Naidenko, A. Attinger, F. Koning, C. J. Lena, Y. Xiong, H. C. Chang, E. Reinherz, M. Kronenberg, and H. Cheroutre. 2001. T cell responses modulated through interaction between CD8αα and the nonclassical MHC class I molecule, TL. Science 294: 1936-1939.
9. lck) that phosphorylates the CD3 complex. Proc. Natl. Acad. Sci. USA 86: 3277-3281.
10. lck tyrosine protein kinase. Mol. Cell. Biol. 10: 1853-1862.
11. lck complexes. J. Exp. Med. 194: 1485-1495.
12. lck. Eur. J. Immunol. 28: 745-754.
13. Doucey, M. A., L. Goffin, D. Naeher, O. Michielin, P. Baumgartner, P. Guillaume, E. Palmer, and I. F. Luescher. 2003. CD3δ establishes a functional link between the T cell receptor and CD8. J. Biol. Chem. 278: 3257-3264.
14. Gakamsky, D. M., I. F. Luescher, A. Pramanik, R. B. Kopito, F. Lemonnier, H. Vogel, R. Rigler, and I. Pecht. 2005. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 89: 2121-2133.
15. Yachi, P. P., J. Ampudia, N. R. Gascoigne, and T. Zal. 2005. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat. Immunol. 6: 785-772.
16. Chang, H. C., K. Tan, J. Ouyang, E. Parisini, J. H. Liu, Y. Le, X. Wang, E. L. Reinherz, and J. H. Wang. 2005. Structural and mutational analyses of a CD8αβ heterodimer and comparison with the CD8αα homodimer. Immunity 23: 661-671.
17. Devine, L., L. J. Kieffer, V. Aitken, and P. B. Kavathas. 2000. Human CD8β, but not mouse CD8β, can be expressed in the absence of CD8α as a ββ homodimer. J. Immunol. 164: 833-838.
18. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94-96.
19. Schatz, P. J. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology 11: 1138-1143.
20. Garboczi, D. N., D. T. Hung, and D. C. Wiley. 1992. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89: 3429-3433.
21. Kinsella, T. M., and G. P. Nolan. 1996. Episomal vectors rapidly and stably produce high-liter recombinant retrovirus. Hum. Gene Ther. 1: 1405-1413.
22. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387: 630-634.
23. b. Immunity 9: 519-530.
24. b and thymic leukemia antigen, while similarly with their α3 domains. J. Immunol. 168: 3881-3886.
25. Wong, J. S., X. Wang, T. Witte, L. Nie, N. Carvou, P. Kern, and H. C. Chang. 2003. Stalk region of β-chain enhances the coreceptor function of CD8. J. Immunol. 171: 867-874.
26. Devine, L., M. E. Hodsdon, M. A. Daniels, S. C. Jameson, and P. B. Kavathas. 2004. Location of the epitope for an anti-CD8α antibody 53.6.7 which enhances CD8α-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation. Immunol. Lett. 93: 123-130.
27. Xue, S., R. Gillmore, A. Downs, A. Tsallios, A. Holler, L. Gao, V. Wong, E. Morris, and H. J. Stauss. 2005. Exploiting T cell receptor genes for cancer immunotherapy. Clin. Exp. Immunol. 139: 167-172.
28. Kershaw, M. H., M. W. Teng, M. J. Smyth, and P. K. Darcy. 2005. Supernatural T cells: genetic modification of T cells for cancer therapy. Nat. Rev. Immunol. 5: 928-940.